$5.35
−9.48%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$5.39
From 52W high−96.35%
Volume48142.00
Market cap$2.17M
P/E (TTM)—
P/S (TTM)0.2x
Div yield—
Key dataNov 4, 2026
Open
$5.39
From 52W high
−96.35%
Volume
48142.00
Market cap
$2.17M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.2x
P/E (TTM)
—
RSI (14)
49.6
MomentumView details →
1D Return
−9.48%
YTD Return
−91.26%
SummaryUpdated Jun 1, 2026
Nuwellis, Inc. (NASDAQ:NUWE) is a medical device company founded in 1999 and headquartered in Eden Prairie, Minnesota. Originally known as CHF Solutions, Inc., the company changed its name to Nuwellis in April 2021. The company specializes in developing, manufacturing, and commercializing medical devices for ultrafiltration therapy, primarily targeting patients with fluid overload conditions who have not responded adequately to traditional diuretic medications. With over two decades of experience in the field, Nuwellis has established itself as a focused player in the specialized medical device market, serving hospitals and clinics both domestically and internationally through direct sales and distributor partnerships.
Similar companies
Latest newsMore news →
Nuwellis announced that it will report financial results for the three and nine months ended September 30, 2026, before U.S. markets open on November 12, 2026.4h agoNuwellis, Inc. announced that the ULTRA-Peds Registry study of Aquadex in 91 pediatric patients across seven children's hospitals was accepted for publication in Nuwellis, Inc..8d agoNuwellis announced that it will convene a Medical & Nursing Advisory Board on November 18–19, 2026, to support development of its Vivian pediatric CRRT platform.27d ago